Opus Genetics, Inc. (IRD) · Oct 21, 2026 · Exec change
CSDO departure — Effective October 19; six-month consulting arrangement
Opus Genetics reports an executive change as its development chief exits, but a six-month consulting deal provides continuity across clinical programs.
Opus Genetics is a clinical-stage biotech advancing a broad inherited-retinal-disease gene-therapy pipeline, led by OPGx-LCA5 and OPGx-BEST1, while moving additional programs toward clinical testing. The company is losing its top scientific and development executive during an execution-heavy phase. Ashwath Jayagopal will transition out of the Chief Scientific and Development Officer role effective October 19. 〔0〕 Because Opus is simultaneously advancing multiple clinical programs, the departure creates some operational and leadership risk rather than being a routine personnel change.
The handoff reduces, but does not eliminate, the disruption. Jayagopal will remain available for six months to provide transition services as requested by the company. 〔1〕 That makes this less abrupt than a clean departure, but the filing does not name a successor or explain who will assume permanent responsibility for scientific and development strategy. The $250-per-hour consulting fee and continued exercisability of vested options are administrative details, not evidence of a new development milestone.
Bottom line: This is a meaningful leadership change at a company approaching several clinical inflection points, softened by a defined transition period. The near-term story is continuity; the unresolved question is who will permanently lead development execution.
Permanent scientific and development leadership appointment
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!